Form 8-K - Current report:
SEC Accession No. 0001558370-21-014923
Filing Date
2021-11-08
Accepted
2021-11-08 07:16:52
Documents
14
Period of Report
2021-11-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20211108x8k.htm   iXBRL 8-K 35502
2 EX-99.1 edit-20211108xex99d1.htm EX-99.1 91955
3 GRAPHIC edit-20211108xex99d1001.jpg GRAPHIC 2566
  Complete submission text file 0001558370-21-014923.txt   262197

Data Files

Seq Description Document Type Size
4 EX-101.SCH edit-20211108.xsd EX-101.SCH 3001
5 EX-101.LAB edit-20211108_lab.xml EX-101.LAB 15386
6 EX-101.PRE edit-20211108_pre.xml EX-101.PRE 9977
7 EXTRACTED XBRL INSTANCE DOCUMENT edit-20211108x8k_htm.xml XML 4678
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 211386514
SIC: 2836 Biological Products, (No Diagnostic Substances)